MARKET

PODD

PODD

Insulet Corp
NASDAQ
132.50
-2.18
-1.62%
Opening 13:35 09/11 EDT
OPEN
135.40
PREV CLOSE
134.68
HIGH
135.58
LOW
131.24
VOLUME
616.22K
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
126.40
MARKET CAP
9.19B
P/E (TTM)
24.78
1D
5D
1M
3M
1Y
5Y
1D
Insulet announces upcoming director resignations amid transitions
TipRanks · 1d ago
Is Insulet (PODD) Cheap As Omnipod Growth Faces New Competition Concerns?
Simply Wall St · 2d ago
Weekly Report: what happened at PODD last week (0831-0904)?
Weekly Report · 4d ago
Should Insulet’s Strong Quarter but Cautious Outlook Require Action From Insulet (PODD) Investors?
Simply Wall St · 5d ago
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinks
Seeking Alpha · 6d ago
Baron SMID Cap ETF Q2 2026 Portfolio Activity
Seeking Alpha · 09/04 15:10
Insulet (PODD), Why Is It Back In The Spotlight?
Simply Wall St · 09/02 17:25
Ten healthcare stocks leading in year-over-year CapEx growth
Seeking Alpha · 09/02 12:02
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.